Type of Submission

Poster

Keywords

Endothelial, monoclonal antibody, cell membrane, signalling, growth factors

Abstract

In various clinical settings such a peripheral vascular disease and diabetes, patients can develop leaky blood vessels that leads to the extravasation of fluid in surrounding tissues, mainly in the lower limbs, ultimately resulting in edema and compromised blood flow. In an attempt to maintain vascular integrity and stability researchers have tried to modulate two key receptors on endothelial cells, Vascular Endothelial Growth Factor Receptor-2 (VEGFR2) and tunica internal endothelial cell kinase 2 (Tie2) receptor using various approaches, including ligand administration and small molecule inhibition of kinase activity on the intracellular part of Tie-2. Various strategies for a therapy include monoclonal antibodies (Mabs) that influence the aforementioned pathways. The current poster describes a monoclonal antibody that binds a cell surface target protein and indirectly modulates the Tie-2 receptor activity.

Faculty Sponsor or Advisor’s Name

Rocco J. Rotello

Campus Venue

Stevens Student Center

Location

Cedarville, OH

Start Date

4-16-2014 11:00 AM

End Date

4-16-2014 2:00 PM

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Share

COinS
 
Apr 16th, 11:00 AM Apr 16th, 2:00 PM

Monoclonal Antibody Activity in Human Umbilical Endothelial Cells That Possess Opposing Growth Factor Signaling Receptors

Cedarville, OH

In various clinical settings such a peripheral vascular disease and diabetes, patients can develop leaky blood vessels that leads to the extravasation of fluid in surrounding tissues, mainly in the lower limbs, ultimately resulting in edema and compromised blood flow. In an attempt to maintain vascular integrity and stability researchers have tried to modulate two key receptors on endothelial cells, Vascular Endothelial Growth Factor Receptor-2 (VEGFR2) and tunica internal endothelial cell kinase 2 (Tie2) receptor using various approaches, including ligand administration and small molecule inhibition of kinase activity on the intracellular part of Tie-2. Various strategies for a therapy include monoclonal antibodies (Mabs) that influence the aforementioned pathways. The current poster describes a monoclonal antibody that binds a cell surface target protein and indirectly modulates the Tie-2 receptor activity.

 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.